These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 34641427)
1. Enhancement of Xu H; Du M; Shen Y; Yang Y; Ding F; Yu S Molecules; 2021 Sep; 26(19):. PubMed ID: 34641427 [No Abstract] [Full Text] [Related]
2. 2-(4-Methoxyphenyl)Ethyl-2-Acetamido-2-Deoxy-β-D-Pyranoside Exerts a Neuroprotective Effect through Regulation of Energy Homeostasis and O-GlcNAcylation. Xu H; Gu H; Yang Y; Cai E; Ding F; Yu S J Mol Neurosci; 2019 Oct; 69(2):177-187. PubMed ID: 31201658 [TBL] [Abstract][Full Text] [Related]
3. 2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside confers neuroprotection in cell and animal models of ischemic stroke through calpain1/PKA/CREB-mediated induction of neuronal glucose transporter 3. Yu S; Cheng Q; Li L; Liu M; Yang Y; Ding F Toxicol Appl Pharmacol; 2014 Jun; 277(3):259-69. PubMed ID: 24726522 [TBL] [Abstract][Full Text] [Related]
4. 2-(4-Methoxyphenyl)ethyl-2-Acetamido-2-deoxy-β-d-pyranoside (A Salidroside Analog) Confers Neuroprotection with a Wide Therapeutic Window by Regulating Local Glucose Metabolism in a Rat Model of Cerebral Ischemic Injury. Yu S; Xu H; Chi X; Wei L; Cheng Q; Yang Y; Zhou C; Ding F Neuroscience; 2018 Nov; 391():60-72. PubMed ID: 30223020 [TBL] [Abstract][Full Text] [Related]
5. 2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-D-pyranoside, an analog of salidroside, contributes to neuroprotection in cerebral ischemic injury in vitro and in vivo. Yu S; Wei L; Chi X; Xu H; Ding F Neuroreport; 2018 Mar; 29(5):426-431. PubMed ID: 29461335 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke. Yu S; Liu X; Shen Y; Xu H; Yang Y; Ding F Neuroscience; 2016 Jul; 327():44-52. PubMed ID: 27060484 [TBL] [Abstract][Full Text] [Related]
7. Effects of O-GlcNAcylation on functional mitochondrial transfer from astrocytes. Park JH; Nakamura Y; Li W; Hamanaka G; Arai K; Lo EH; Hayakawa K J Cereb Blood Flow Metab; 2021 Jul; 41(7):1523-1535. PubMed ID: 33153373 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-D-pyranoside attenuates cerebral ischemia/reperfusion-induced injury in vitro and in vivo. Chen X; Deng A; Zhou T; Ding F PLoS One; 2014; 9(7):e100126. PubMed ID: 24991917 [TBL] [Abstract][Full Text] [Related]
9. Regulation of mitochondrial network homeostasis by O-GlcNAcylation. Xue Q; Yan R; Ji S; Yu S Mitochondrion; 2022 Jul; 65():45-55. PubMed ID: 35513218 [TBL] [Abstract][Full Text] [Related]
11. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells. Johnson B; Opimba M; Bernier J Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784 [TBL] [Abstract][Full Text] [Related]
12. Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies. Pinho TS; Correia SC; Perry G; Ambrósio AF; Moreira PI Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2048-2059. PubMed ID: 30412792 [TBL] [Abstract][Full Text] [Related]
16. Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. Hu Y; Suarez J; Fricovsky E; Wang H; Scott BT; Trauger SA; Han W; Hu Y; Oyeleye MO; Dillmann WH J Biol Chem; 2009 Jan; 284(1):547-555. PubMed ID: 19004814 [TBL] [Abstract][Full Text] [Related]
17. High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation. Dassanayaka S; Readnower RD; Salabei JK; Long BW; Aird AL; Zheng YT; Muthusamy S; Facundo HT; Hill BG; Jones SP Biochem J; 2015 Apr; 467(1):115-26. PubMed ID: 25627821 [TBL] [Abstract][Full Text] [Related]
18. Acute Increases in Protein O-GlcNAcylation Dampen Epileptiform Activity in Hippocampus. Stewart LT; Khan AU; Wang K; Pizarro D; Pati S; Buckingham SC; Olsen ML; Chatham JC; McMahon LL J Neurosci; 2017 Aug; 37(34):8207-8215. PubMed ID: 28760863 [TBL] [Abstract][Full Text] [Related]
19. Dynamic O-linked N-acetylglucosamine modification of proteins affects stress responses and survival of mesothelial cells exposed to peritoneal dialysis fluids. Herzog R; Bender TO; Vychytil A; Bialas K; Aufricht C; Kratochwill K J Am Soc Nephrol; 2014 Dec; 25(12):2778-88. PubMed ID: 24854264 [TBL] [Abstract][Full Text] [Related]